Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for ...

Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't ...

NEW YORK, Oct. 28 (UPI) --New blood tests screen for colorectal cancer in a much less invasive way than colonoscopy, but deaths will increase if many people choose this alternative, a new study ...

Colon cancer treatment is personalized based on stage, overall health and tumor characteristics. Early detection and accurate ...

FIT checks for blood in the stool, which can indicate the presence of colorectal cancer or polyps. Patients collect stool ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Millions remain unscreened for colorectal cancer. Learn how noninvasive screening can expand access, preserve capacity, and ...

An investigational blood test for early detection of colorectal cancer (CRC) in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC study, the largest study ...

(a) “You don’t have to worry about that. Colon cancer is mainly a man’s disease.” (b) “Yes, everyone should have a colonoscopy every year to check for colon cancer.” (c) “I’ll do a rectal exam today, ...